95 / 1631
Fig. 2. Kaplan–Meier analysis of overall survival in study MDX010-20.
Durable benefit and the potential for long-term
survival with immunotherapy in advanced melanoma
D McDermott, et al
Cancer Treatment Reviews, Volume 40, Issue 9, 2014, 1056–1064